Ataraxis AI develops AI foundation models for cancer diagnostics and personalized treatment plans.
Ataraxis AI is listed on Rocketlist with 10 active roles. The company is categorized as AI & ML in Oncology in HealthTech. Ataraxis AI is at Series A stage, with a B2B business model, headquartered in New York, United States. Ataraxis AI was founded in 2022. Ataraxis AI has raised $40M. Active roles are refreshed daily from public hiring sources.